PhaseV, a leader in AI/ML for clinical development, today announced the launch of its AI Conductor, a centralized platform ...
Clinical trial protocols lay the foundation for R&D, but they aren’t enough to ensure success. People, processes, and ...
Clinical Trials Arena on MSN
PhaseV unveils centralised platform to automate clinical trials
AI Conductor operates as an orchestration layer across PhaseV’s vertical AI platform.
The newly introduced AI-powered study build engine marks the first phase of ClinCapture's broader intelligent trial roadmap. By automating protocol translation, Captivate establishes a foundation for ...
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date The ...
Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
Investigator-initiated trials are uniquely unsuited to a patchwork of Google Drive folders, Excel worksheets, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results